Share this article and save a life!
18.3 billion patient encounters at your fingertips. Game changer?
Advocate Health just plugged into Epic’s Cosmos platform, and the numbers are staggering.
300 million patient records. Real-world data. Instant access.
Here’s what this means for healthcare innovation:
Their DIVE team can now visualize patterns across populations that were invisible before. Think about it: rare disease clusters, medication effectiveness across demographics, social determinants impacting outcomes.
The platform has already powered 165 publications across 112 journals. From chronic disease surveillance to antibiotic resistance patterns.
But here’s what excites me most:
The “Look-Alikes” feature connects providers treating rare conditions. Imagine being the only doctor in your state treating a rare genetic disorder, then instantly connecting with 20 others who’ve seen similar cases.
No more practicing in isolation.
This isn’t just about big data. It’s about turning every patient encounter into collective learning.
When 60 million patients became part of Cosmos two years ago, skeptics worried about privacy and data security. Now we’re at 300 million, with health systems racing to join.
The April 28 Cosmos Symposium in Verona will showcase what’s next. But the real question is:
Can smaller health systems and FQHCs access these insights too? Or will data-driven care become another divide between the haves and have-nots?
Data democratization or data monopoly? The next 12 months will tell.
♻️ Repost if health data collaboration needs to include all providers, not just the giants.
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:

Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.




